DaVita
DVA
#2031
Rank
$10.07 B
Marketcap
$150.73
Share price
2.30%
Change (1 day)
6.12%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): $10.12

According to DaVita's latest financial reports the company's current EPS (TTM) is $10.12. In 2024 the company made an earnings per share (EPS) of $11.03 an increase over its 2023 EPS that were of $7.61.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$10.12-8.25%
2024$11.0344.94%
2023$7.6127.26%
2022$5.98-35.56%
2021$9.2844.1%
2020$6.4419.7%
2019$5.38540.48%
2018$0.84-76.07%
2017$3.51-19.31%
2016$4.35242.52%
2015$1.27-62.87%
2014$3.4213.43%
2013$3.018.45%
2012$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
$21.35 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$10.25 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
$14.70 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
$1.90-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA